牛叉诊股

[{"date":"2026.08.03","stock":"1.46","trade":"0.14","ind":"-0.96"},{"date":"2026.07.31","stock":"1.09","trade":"2.21","ind":"2.21"},{"date":"2026.07.30","stock":"2.14","trade":"-2.19","ind":"-2.73"},{"date":"2026.07.29","stock":"0.88","trade":"0.94","ind":"1.10"},{"date":"2026.07.28","stock":"0.32","trade":"-1.95","ind":"-4.52"},{"date":"2026.07.27","stock":"2.89","trade":"3.13","ind":"2.72"},{"date":"2026.07.24","stock":"-4.34","trade":"-3.95","ind":"-2.47"},{"date":"2026.07.23","stock":"-2.08","trade":"-0.26","ind":"0.44"},{"date":"2026.07.22","stock":"0.39","trade":"-0.90","ind":"-1.42"},{"date":"2026.07.21","stock":"1.10","trade":"-0.66","ind":"4.81"},{"date":"2026.07.20","stock":"3.99","trade":"0.38","ind":"-0.71"},{"date":"2026.07.17","stock":"-5.32","trade":"-7.01","ind":"-5.40"},{"date":"2026.07.16","stock":"3.85","trade":"0.36","ind":"-1.97"},{"date":"2026.07.15","stock":"3.48","trade":"2.67","ind":"-0.97"},{"date":"2026.07.14","stock":"1.34","trade":"2.74","ind":"2.77"},{"date":"2026.07.13","stock":"-2.22","trade":"-1.36","ind":"-3.48"},{"date":"2026.07.10","stock":"7.04","trade":"3.33","ind":"-2.29"},{"date":"2026.07.09","stock":"-0.52","trade":"0.10","ind":"3.07"},{"date":"2026.07.08","stock":"-1.55","trade":"-1.54","ind":"-1.87"},{"date":"2026.07.07","stock":"-4.99","trade":"-4.28","ind":"-1.24"},{"date":"2026.07.06","stock":"0.41","trade":"1.41","ind":"-1.16"}]

智飞生物,深证成指,生物制品指数

压力支撑

该股压力位为13.03元，支撑位为12.84元。

[{"text":"\u538b\u529b\u4f4d","value":"13.03","date":1785686400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"12.84","date":1785686400,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前正处于反弹阶段，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：4.2资金面打败了41%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

生物制品行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：08月04日 08:06

机构今日流向(万元)	-623.73	机构5日流向(万元)	-2270.36
机构10日流向(万元)	-5164.49	机构20日流向(万元)	-3544.81

机构持仓

2026-06-30 与 2025-12-31 相比，主力机构持仓量减少27492.44万股，其中基金净增仓6家，主力净减仓376家，暂未发现中长期投资价值。

截止2026-06-30，共8家主力机构（基金8家），持仓量总计342.65万股，占流通A股0.24%
其中，基金持仓与2025-12-31相比：
增仓：6家，增持 81.26万股
减仓：0家，减持 0万股
新出现在主力名单中：2家，持有5.87万股
从主力名单中消失：378家，原持有27579.57万股

消息面诊股

诊断结果：5.3消息面打败了28%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	重大事项	公司股东股份解押	2026-06-25
利空	重大事项	公司违规：处罚类型	2026-05-08
一般消息	股东大会	年度股东大会	2026-04-28
一般消息	分红转增	不分配不转增	2026-04-28
一般消息	重大事项	关联交易	2026-04-28
一般消息	重大事项	公司股东股份解押	2026-03-17
利空	业绩预告	业绩预亏	2026-01-12
一般消息	重大事项	关联交易	2026-01-05
一般消息	高管变动	取消监事会	2025-11-18
一般消息	高管变动	因公司治理结构及内部工作调整	2025-10-28
一般消息	分红转增	不分配不转增	2025-08-19
一般消息	重大事项	关联交易	2025-08-19

一年消息统计

	所有消息	重大消息	非重大消息
利好	0条	0条	0条
利空	2条	0条	2条

行业面诊股

诊断结果：5.4行业面打败了67%的股票生物制品行业最新资金流向

近10日来该行业走势不明显，明显跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，明显跑输大盘。

[{"date":"2026.08.03","price":"-0.96","value":"0.14"},{"date":"2026.07.31","price":"2.21","value":"2.21"},{"date":"2026.07.30","price":"-2.73","value":"-2.19"},{"date":"2026.07.29","price":"1.10","value":"0.94"},{"date":"2026.07.28","price":"-4.52","value":"-1.95"},{"date":"2026.07.27","price":"2.72","value":"3.13"},{"date":"2026.07.24","price":"-2.47","value":"-3.95"},{"date":"2026.07.23","price":"0.44","value":"-0.26"},{"date":"2026.07.22","price":"-1.42","value":"-0.90"},{"date":"2026.07.21","price":"4.81","value":"-0.66"},{"date":"2026.07.20","price":"-0.71","value":"0.38"},{"date":"2026.07.17","price":"-5.40","value":"-7.01"},{"date":"2026.07.16","price":"-1.97","value":"0.36"},{"date":"2026.07.15","price":"-0.97","value":"2.67"},{"date":"2026.07.14","price":"2.77","value":"2.74"},{"date":"2026.07.13","price":"-3.48","value":"-1.36"},{"date":"2026.07.10","price":"-2.29","value":"3.33"},{"date":"2026.07.09","price":"3.07","value":"0.10"},{"date":"2026.07.08","price":"-1.87","value":"-1.54"},{"date":"2026.07.07","price":"-1.24","value":"-4.28"},{"date":"2026.07.06","price":"-1.16","value":"1.41"}]

深证成指,生物制品行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	-	44.59%	51.80%	分
2	上海莱士	13.39%	3.55%	5.9分
3	长春高新	13.22%	-1.45%	5.5分
4	派林生物	9.48%	9.82%	6.2分
5	智飞生物	8.27%	6.01%	5.9分
6	博晖创新	6.39%	4.09%	5.9分
7	天坛生物	5.04%	5.21%	5.6分
8	康泰生物	4.85%	3.72%	5.8分
9	四环生物	4.53%	1.93%	5.2分
10	辽宁成大	4.49%	2.34%	5.5分
11	华兰生物	4.43%	5.72%	5.8分
12	*ST未名	4.20%	5.15%	5.5分
13	博雅生物	4.12%	8.01%	5.9分
14	华兰疫苗	3.31%	5.70%	6.1分
15	甘李药业	1.18%	4.93%	6.0分
16	百克生物	0.53%	5.02%	6.0分
17	西藏药业	0.05%	2.82%	5.8分
18	特宝生物	-0.07%	-3.53%	5.4分
19	安科生物	-0.36%	2.83%	6.3分
20	通化东宝	-0.36%	3.85%	6.3分
21	义翘神州	-0.61%	0.94%	5.4分
22	成大生物	-0.64%	2.90%	5.6分
23	我武生物	-2.70%	-0.26%	5.0分
24	康华生物	-4.68%	4.72%	5.7分
25	东宝生物	-4.72%	3.42%	5.4分
26	康希诺	-4.75%	2.52%	5.5分
27	诺唯赞	-5.17%	-8.84%	6.0分
28	优宁维	-6.15%	3.91%	5.8分
29	沃森生物	-6.88%	-0.32%	5.2分
30	康弘药业	-6.99%	0.05%	5.3分
31	君实生物	-7.06%	-5.14%	5.2分
32	百奥泰	-7.24%	1.75%	5.1分
33	近岸蛋白	-8.87%	2.75%	5.0分
34	康辰药业	-9.19%	-6.92%	5.1分
35	百普赛斯	-9.27%	-15.82%	4.7分
36	卫光生物	-10.03%	5.54%	5.1分
37	赛升药业	-10.64%	-0.78%	4.6分
38	智翔金泰	-11.39%	-4.92%	4.3分
39	金迪克	-12.42%	6.41%	5.4分
40	双成药业	-13.14%	2.57%	6.2分
41	艾迪药业	-14.90%	-17.15%	4.8分
42	神州细胞	-15.00%	-2.59%	5.3分
43	诺诚健华	-16.86%	-10.35%	4.6分
44	-	-17.86%	0.66%	分
45	科兴制药	-20.63%	-0.95%	5.6分
46	迈威生物	-20.87%	-15.19%	4.3分
47	万泽股份	-23.39%	-6.22%	5.3分
48	昊帆生物	-24.77%	-16.11%	4.9分
49	荣昌生物	-24.79%	-12.91%	5.1分
50	-	-27.15%	-5.78%	分
51	三生国健	-30.48%	-8.76%	5.1分
52	禾元生物	-37.34%	-26.77%	5.1分
53	赛伦生物	-41.60%	-10.41%	4.2分
54	欧林生物	-48.51%	-8.78%	4.7分
55	泰诺麦博	-	-16.38%	4.4分

<上一页 1 2 3 4 5...10 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：5.6基本面打败了40%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，暂时未获得多数机构的显著认同，后续可继续关注。

个股深一度

潜在高分红能力：中（97.5分）

基本面得分最高的股票

[ 截止日期：2026-03-31 ]公司经营

盈利能力：较强，高于行业平均，两项指标的行业排名分别为 45/71 ， 46/71。

[{"date":"2026-03-31","value":"-2.48","vol":"-6.01"},{"date":"2025-12-31","value":"-63.06","vol":"-12.99"},{"date":"2025-09-30","value":"-4.42","vol":"-10.09"},{"date":"2025-06-30","value":"-1.96","vol":"-0.66"},{"date":"2025-03-31","value":"-1.05","vol":"-0.34"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净资产收益率(%)	-2.48	-63.06	-4.42	-1.96	-1.05
行业(%)	-6.01	-12.99	-10.09	-0.66	-0.34

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"29.16","vol":"61.43"},{"date":"2025-12-31","value":"7.84","vol":"66.53"},{"date":"2025-09-30","value":"21.82","vol":"67.71"},{"date":"2025-06-30","value":"28.30","vol":"66.67"},{"date":"2025-03-31","value":"32.01","vol":"38.38"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
销售毛利率(%)	29.16	7.84	21.82	28.30	32.01
行业(%)	61.43	66.53	67.71	66.67	38.38

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 37/71 ， 28/71。

[{"date":"2026-03-31","value":"-8.64","vol":"297.05"},{"date":"2025-12-31","value":"-65.61","vol":"39.85"},{"date":"2025-09-30","value":"-66.45","vol":"45.81"},{"date":"2025-06-30","value":"-73.05","vol":"6902.14"},{"date":"2025-03-31","value":"-79.39","vol":"6125.11"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
营业收入同比增长率(%)	-8.64	-65.61	-66.45	-73.05	-79.39
行业(%)	297.05	39.85	45.81	6902.14	6125.11

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"-18.79","vol":"74.22"},{"date":"2025-12-31","value":"-846.42","vol":"33.79"},{"date":"2025-09-30","value":"-162.57","vol":"45.67"},{"date":"2025-06-30","value":"-126.62","vol":"5.21"},{"date":"2025-03-31","value":"-121.91","vol":"-8.79"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净利润同比增长率(%)	-18.79	-846.42	-162.57	-126.62	-121.91
行业(%)	74.22	33.79	45.67	5.21	-8.79

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：较强，高于行业平均，两项指标的行业排名分别为 17/71 ， 10/71。

[{"date":"2026-03-31","value":"0.07","vol":"0.06"},{"date":"2025-12-31","value":"0.22","vol":"0.29"},{"date":"2025-09-30","value":"0.16","vol":"0.21"},{"date":"2025-06-30","value":"0.10","vol":"0.13"},{"date":"2025-03-31","value":"0.05","vol":"0.06"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
总资产周转率(次)	0.07	0.22	0.16	0.10	0.05
行业(次)	0.06	0.29	0.21	0.13	0.06

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.36","vol":"0.29"},{"date":"2025-12-31","value":"0.61","vol":"1.29"},{"date":"2025-09-30","value":"0.28","vol":"0.90"},{"date":"2025-06-30","value":"0.16","vol":"0.55"},{"date":"2025-03-31","value":"0.07","vol":"0.25"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
存货增长率(次)	0.36	0.61	0.28	0.16	0.07
行业(次)	0.29	1.29	0.90	0.55	0.25

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-03-31","value":"12.93","vol":"-78.67"},{"date":"2025-12-31","value":"166.07","vol":"12.85"},{"date":"2025-09-30","value":"52.25","vol":"0.21"},{"date":"2025-06-30","value":"49.00","vol":"-1377.65"},{"date":"2025-03-31","value":"12.93","vol":"-2083.82"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
现金流量净额/营业收入	12.93	166.07	52.25	49.00	12.93
行业	-78.67	12.85	0.21	-1377.65	-2083.82

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"1.16","vol":"1.74"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.00","vol":"1.55"},{"date":"2025-03-31","value":"","vol":"0.00"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资本支出／折旧和摊销	-	1.16	-	1.00	-
行业	0.00	1.74	0.00	1.55	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 19/71 ， 24/71。

[{"date":"2026-03-31","value":"3.14","vol":"6.66"},{"date":"2025-12-31","value":"1.53","vol":"5.80"},{"date":"2025-09-30","value":"2.78","vol":"6.07"},{"date":"2025-06-30","value":"2.45","vol":"6.57"},{"date":"2025-03-31","value":"2.30","vol":"7.73"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
流动比率	3.14	1.53	2.78	2.45	2.30
行业	6.66	5.80	6.07	6.57	7.73

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"2.43","vol":"5.14"},{"date":"2025-12-31","value":"1.12","vol":"4.43"},{"date":"2025-09-30","value":"1.21","vol":"4.89"},{"date":"2025-06-30","value":"1.06","vol":"5.24"},{"date":"2025-03-31","value":"1.03","vol":"6.33"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
速动比率	2.43	1.12	1.21	1.06	1.03
行业	5.14	4.43	4.89	5.24	6.33

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 8/71 ， 14/71。

[{"date":"2026-03-31","value":"45.99","vol":"28.78"},{"date":"2025-12-31","value":"49.22","vol":"28.75"},{"date":"2025-09-30","value":"36.42","vol":"28.02"},{"date":"2025-06-30","value":"34.18","vol":"26.19"},{"date":"2025-03-31","value":"36.85","vol":"26.65"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资产负债率(%)	45.99	49.22	36.42	34.18	36.85
行业(%)	28.78	28.75	28.02	26.19	26.65

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.87","vol":"2.54"},{"date":"2025-12-31","value":"0.99","vol":"1.42"},{"date":"2025-09-30","value":"0.58","vol":"0.58"},{"date":"2025-06-30","value":"0.52","vol":"1.11"},{"date":"2025-03-31","value":"0.58","vol":"0.80"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
产权比率 (%)	0.87	0.99	0.58	0.52	0.58
行业(%)	2.54	1.42	0.58	1.11	0.80

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

机构预测该股2026年每股收益与前一年相同，长期投资价值一般。

[{"date":"2022","yellowRectValue":"75.39","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"81.08","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"20.06","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-147.23","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"-12.52","blueLineValue":"-0.52","type":"YC"}]

[智飞生物]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]